Stocktoria
Drugs Made In America Acquisition II Corp. DMII
Nasdaq · XNAS · stock · Blank Checks · IPO 2025-09-25
Chart by TradingView
1/9
Piotroski F — financial health
-1.17
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 |
|---|---|
| Financials | |
| Operating income | -$488,385 |
| Net income | $4.2M |
| Operating cash flow | -$1.0M |
| Total assets | $505.0M |
| Total liabilities | $17.8M |
| Shareholders' equity | -$17.8M |
| Ratios | |
| Return on assets | 0.8% |
| Return on equity | -23.6% |
| Current ratio | 0.09 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.17 (distress)
- Working capital / assets -0.001
- Retained earnings / assets -0.035
- EBIT / assets -0.001
- Equity / liabilities -0.999
Sector peers
IX · MUFG · MFG · NMR · UNH · CI · all Finance, Insurance & Real Estate →
Source: SEC EDGAR filings · CIK 0002040475 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.